| Trial Identifier: | GM-IMAB-001-02 |
| Sponsor: | Ganymed Pharmaceuticals GmbH |
| Start Date: | September 2010 |
| Primary Completion Date: | August 2015 |
| Study Completion Date: | August 2015 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Bulgaria | Varna, Bulgaria, 9002 |
| Bulgaria | Varna, Bulgaria, 9010 |
| Bulgaria | Veliko Turnovo, Bulgaria, 5000 |
| Germany | Berlin, Germany, 13353 |
| Germany | Bochum, Germany, 44892 |
| Germany | Braunschweig, Germany, 38114 |
| Germany | Essen, Germany, 45122 |
| Germany | Frankfurt, Germany, 60488 |
| Germany | Halle, Germany, 06120 |
| Germany | Hamburg, Germany, 20246 |
| Germany | Hamburg, Germany, 20249 |
| Germany | Heidelberg, Germany, 69120 |
| Germany | Leipzig, Germany, 04103 |
| Germany | Mainz, Germany, 55101 |
| Germany | Muenchen, Germany, 81675 |
| Germany | Ulm, Germany, 89081 |
| Latvia | Liepaja, Latvia |
| Latvia | Riga, Latvia, 1002 |
| Latvia | Riga, Latvia, 1038 |
| Lithuania | Vilnius, Lithuania, 08660 |
| Switzerland | St.Gallen, Switzerland, 9007 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company